STAT6 is a cytokine-responsive transcription factor that links receptor signaling to gene regulation in immune cells
[1]. Mechanistically, IL-4 and IL-13 activate STAT6, and this axis drives T
H2 polarization, IL-4-dependent lymphocyte responses, and IgE class switching
[1][2][3]. In disease models, STAT6 regulates pathologic lung inflammation and supports experimental analysis of allergic asthma, airway hyperresponsiveness, and atopic inflammation
[4][5][6]. Compared with related STAT isoforms, STAT6 shows a distinct functional focus on IL-4/IL-13 biology, whereas STAT4 primarily controls T
H1 differentiation
[7]. For experimental applications, STAT6 inhibition with AS1517499 reduced antigen-induced bronchial hypercontractility and blocked STAT6 signaling in mouse atopic dermatitis-asthma models
[5][6].